Antigen-specific T-cell responses to a recombinant fowlpox virus are dependent on MyD88 and interleukin-18 and independent of toll-like receptor 7 (TLR7)- and TLR9-mediated innate immune recognition

Journal of Virology

Volumn 85, Issue 7, 2011, Pages 3385-3396

  Lousberg, Erin L ^a,b   Diener, Kerrilyn R ^a,b   Fraser, Cara K ^a,b   Phipps, Simon ^c   Foster, Paul S ^d   Chen, Weisan ^e   Uematsu, Satoshi ^f   Akira, Shizuo ^f   Robertson, Sarah A ^g   Brown, Michael P ^a,g,h   Hayball, John D ^a,b,g  

^a HANSON INSTITUTE   (Australia)

^b UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d UNIVERSITY OF NEWCASTLE   (Australia)

^e LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

^f OSAKA UNIVERSITY   (Japan)

^g UNIVERSITY OF ADELAIDE   (Australia)

^h ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; INTERLEUKIN 1; INTERLEUKIN 18; MYELOID DIFFERENTIATION FACTOR 88; OVALBUMIN; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN SPECIFICITY; ARTICLE; CELL COMPARTMENTALIZATION; CELL MATURATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; FOWLPOX VIRUS; IN VIVO STUDY; INNATE IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; VIRUS CELL INTERACTION; VIRUS RECOMBINANT;

ANIMALS; CHICKENS; FOWLPOX VIRUS; INTERLEUKIN-18; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MYELOID DIFFERENTIATION FACTOR 88; OVALBUMIN; RECOMBINANT PROTEINS; T-LYMPHOCYTES; TOLL-LIKE RECEPTOR 7; TOLL-LIKE RECEPTOR 9; VIRAL VACCINES;

DNA VIRUSES; FOWLPOX VIRUS; MAMMALIA;

EID: 79952611701     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02000-10     Document Type: Article

References (77)

1. Adachi, O., et al. 1998. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9:143-150. (Pubitemid 28361303)
2. Alexopoulou, L., A. C. Holt, R. Medzhitov, and R. A. Flavell. 2001. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413:732-738.
3. Barr, D. P., et al. 2007. A role for plasmacytoid dendritic cells in the rapid IL-18-dependent activation of NK cells following HSV-1 infection. Eur. J. Immunol. 37:1334-1342.
4. Beukema, E. L., M. P. Brown, and J. D. Hayball. 2006. The potential role of fowlpox virus in rational vaccine design. Expert Rev. Vaccines 5:565-577.
5. Bianchi, M. E., and A. A. Manfredi. 2007. High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity. Immunol. Rev. 220:35-46.
6. Boyle, D., A. Pye, and B. Coupar. 1996. Comparison of field and vaccine strains of Australian fowlpox viruses. Arch. Virol. 142:737-748.
7. Brasel, K., T. De Smedt, J. L. Smith, and C. R. Maliszewski. 2000. Generation of murine dendritic cells from flt3-ligand-supplemented bone marrow cultures. Blood 96:3029-3039.
8. Carmody, R. J., and Y. H. Chen. 2007. Nuclear factor-kappaB: activation and regulation during Toll-like receptor signaling. Cell. Mol. Immunol. 4:31-41.
9. Carter, G. C., M. Law, M. Hollinshead, and G. L. Smith. 2005. Entry of the vaccinia virus intracellular mature virion and its interactions with glycosaminoglycans. J. Gen. Virol. 86:1279-1290.
10. Castiglioni, A., V. Canti, P. Rovere-Querini, and A. A. Manfredi. 2011. High-mobility group box 1 (HMGB1) as a master regulator of innate immunity. Cell Tissue Res. 343:189-199.
11. Cookson, B. T., and M. A. Brennan. 2001. Pro-inflammatory programmed cell death. Trends Microbiol. 9:113-114.
12. Delaloye, J., et al. 2009. Innate immune sensing of modified vaccinia virus Ankara (MVA) is mediated by TLR2-TLR6, MDA-5 and the NALP3 inflammasome. PLoS Pathog. 5:e1000480.
13. Denton, A. E., P. C. Doherty, S. J. Turner, and N. L. La Gruta. 2007. IL-18, but not IL-12, is required for optimal cytokine production by influenza virus-specific CD8+ T cells. Eur. J. Immunol. 37:368-375.
14. Diebold, S. S., T. Kaisho, H. Hemmi, S. Akira, and C. Reis e Sousa. 2004. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303:1529-1531.
15. Diener, K. R., et al. 2008. Recombinant fowlpox virus elicits transient cytotoxic T cell responses due to suboptimal innate recognition and recruitment of T cell help. Vaccine 26:3566-3573.
16. Dinarello, C. A. 2009. Immunological and inflammatory functions of the interleukin-1 family. Annu. Rev. Immunol. 27:519-550.
17. Edwards, A. D., et al. 2003. Toll-like receptor expression in murine DC subsets: lack of TLR7 expression by CD8 alpha+ DC correlates with unresponsiveness to imidazoquinolines. Eur. J. Immunol. 33:827-833.
18. Emery, S., et al. 2007. Influence of IFNgamma co-expression on the safety and antiviral efficacy of recombinant fowlpox virus HIV therapeutic vaccines following interruption of antiretroviral therapy. Hum. Vaccin. 3:260-267.
19. Franchi, L., T. Eigenbrod, R. Munoz-Planillo, and G. Nunez. 2009. The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nat. Immunol. 10:241-247.
20. Fraser, C. K., K. R. Diener, M. P. Brown, and J. D. Hayball. 2007. Improving vaccines by incorporating immunological coadjuvants. Expert Rev. Vaccines 6:559-578.
21. Fraser, C. K., et al. 2010. Induction of both cellular and humoral immunity following a rational prime-boost immunization regimen that incorporates recombinant ovine atadenovirus and fowlpox virus. Clin. Vaccine Immunol. 17:1679-1686.
22. French, M. A., et al. 2010. Vaccine-induced IgG2 anti-HIV p24 is associated with control of HIV in patients with a 'high affinity' FcγRIIa genotype. AIDS 24:1983-1990.
23. Gardella, S., C. Andrei, A. Poggi, M. R. Zocchi, and A. Rubartelli. 2000. Control of interleukin-18 secretion by dendritic cells: role of calcium influxes. FEBS Lett. 481:245-248.
24. Gilliet, M., et al. 2002. The development of murine plasmacytoid dendritic cell precursors is differentially regulated by FLT3-ligand and granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 195:953-958.
25. Greenough, T. C., et al. 2008. Safety and immunogenicity of recombinant poxvirus HIV-1 vaccines in young adults on highly active antiretroviral therapy. Vaccine 26:6883-6893.
26. Gu, Y., et al. 1997. Activation of interferon-gamma inducing factor mediated by interleukin-1beta converting enzyme. Science 275:206-209. (Pubitemid 27034760)
27. Gulley, J. L., et al. 2009. Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancer. Cancer Immunol. Immunother. 59:663-674.
28. Gulley, J. L., et al. 2008. Pilot study of vaccination with recombinant CEA-MUC-1-TRICOM poxviral-based vaccines in patients with metastatic carcinoma. Clin. Cancer Res. 14:3060-3069.
29. Hacker, H., et al. 1998. CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation. EMBO J. 17:6230-6240. (Pubitemid 28497796)
30. Hemmi, H., et al. 2002. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat. Immunol. 3:196-200.
31. Hemmi, H., et al. 2000. A Toll-like receptor recognizes bacterial DNA. Nature 408:740-745. (Pubitemid 32015992)
32. Hoebe, K., et al. 2003. Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature 424:743-748. (Pubitemid 37021696)
33. Huang, Q., et al. 2001. The plasticity of dendritic cell responses to pathogens and their components. Science 294:870-875. (Pubitemid 33032108)
34. Ishikawa, H., Z. Ma, and G. N. Barber. 2009. STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature 461:788-792.
35. Kawai, T., and S. Akira. 2010. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 11:373-384.
36. Kepp, O., L. Galluzzi, L. Zitvogel, and G. Kroemer. 2010. Pyroptosis - a cell death modality of its kind? Eur. J. Immunol. 40:627-630.
37. Krug, A., et al. 2004. TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function. Immunity 21:107-119. (Pubitemid 38925271)
38. Kumar, S., and D. B. Boyle. 1990. A poxvirus bidirectional promoter element with early/late and late functions. Virology 179:151-158.
39. Labow, M., et al. 1997. Absence of IL-1 signaling and reduced inflammatory response in IL-1 type I receptor-deficient mice. J. Immunol. 159:2452-2461. (Pubitemid 127681040)
40. Lechleider, R. J., et al. 2008. Safety and immunologic response of a viral vaccine to prostate-specific antigen in combination with radiation therapy when metronomic-dose interleukin 2 is used as an adjuvant. Clin. Cancer Res. 14:5284-5291.
41. Lindsay, R. W., et al. 2010. CD8+ T cell responses following replication-defective adenovirus serotype 5 immunization are dependent on CD11c+ dendritic cells but show redundancy in their requirement of TLR and nucleotide-binding oligomerization domain-like receptor signaling. J. Immunol. 185:1513-1521.
42. Lotze, M. T., and K. J. Tracey. 2005. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat. Rev. Immunol. 5:331-342.
43. Lousberg, E. L., C. K. Fraser, M. G. Tovey, K. R. Diener, and J. D. Hayball. 2010. Type I interferons mediate the innate cytokine response to recombinant fowlpox virus but not the induction of plasmacytoid-dependent adaptive immunity. J. Virol. 84:6549-6563.
44. Lund, J., A. Sato, S. Akira, R. Medzhitov, and A. Iwasaki. 2003. Toll-like receptor 9-mediated recognition of herpes simplex virus-2 by plasmacytoid dendritic cells. J. Exp. Med. 198:513-520.
45. Macagno, A., G. Napolitani, A. Lanzavecchia, and F. Sallusto. 2007. Duration, combination and timing: the signal integration model of dendritic cell activation. Trends Immunol. 28:227-233. (Pubitemid 46654873)
46. Mannel, D. N., S. B. Mizel, T. Diamantstein, and W. Falk. 1985. Induction of interleukin 2 responsiveness in thymocytes by synergistic action of interleukin 1 and interleukin 2. J. Immunol. 134:3108-3110. (Pubitemid 16238279)
47. Matsumoto, M., and T. Seya. 2008. TLR3: interferon induction by double-stranded RNA including poly(I:C). Adv. Drug Deliv. Rev. 60:805-812.
48. Mercer, J., and A. Helenius. 2008. Vaccinia virus uses macropinocytosis and apoptotic mimicry to enter host cells. Science 320:531-535. (Pubitemid 351590666)
49. Naik, S. H., et al. 2005. Generation of splenic CD8+ and CD8- dendritic cell equivalents in fms-like tyrosine kinase 3 ligand bone marrow cultures. J. Immunol. 174:6592-6597. (Pubitemid 40705619)
50. Netea, M. G., J. W. M. Van der Meer, R. P. Sutmuller, G. J. Adema, and B.-J. Kullberg. 2005. From the Th1/Th2 paradigm towards a Toll-like receptor/T-helper bias. Antimicrob. Agents Chemother. 49:3991-3996.
51. Nuara, A. A., et al. 2008. Structure and mechanism of IFN-gamma antagonism by an orthopoxvirus IFN-gamma-binding protein. Proc. Natl. Acad. Sci. U. S. A. 105:1861-1866.
52. O'Callaghan, C., et al. 1999. BirA enzyme: production and application in the study of membrane receptor-ligand interactions by site-specific biotinylation. Anal. Biochem. 266:9-15.
53. Omoto, Y., et al. 2010. Granzyme B is a novel interleukin-18 converting enzyme. J. Dermatol. Sci. 59:129-135.
54. Puehler, F., et al. 2003. An interferon-gamma-binding protein of novel structure encoded by the fowlpox virus. J. Biol. Chem. 278:6905-6911.
55. Radaelli, A., E. Pozzi, S. Pacchioni, C. Zanotto, and C. de Giuli Morghen. 2010. Fowlpox virus recombinants expressing HPV-16 E6 and E7 oncogenes for the therapy of cervical carcinoma elicit humoral and cell-mediated responses in rabbits. J. Transl. Med. 8:40.
56. Rerks-Ngarm, S., et al. 2009. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N. Engl. J. Med. 361:2209-2220.
57. Roberts, T. L., et al. 2009. HIN-200 proteins regulate caspase activation in response to foreign cytoplasmic DNA. Science 323:1057-1060.
58. Rosenberg, S. A., et al. 2003. Recombinant fowlpox viruses encoding the anchor-modified gp100 melanoma antigen can generate antitumor immune responses in patients with metastatic melanoma. Clin. Cancer Res. 9:2973-2980.
59. Sakala, I. G., et al. 2007. Poxvirus-encoded gamma interferon binding protein dampens the host immune response to infection. J. Virol. 81:3346-3353. (Pubitemid 46456643)
60. Savarino, A., J. R. Boelaert, A. Cassone, G. Majori, and R. Cauda. 2003. Effects of chloroquine on viral infections: an old drug against today's diseases? Lancet Infect. Dis. 3:722-727. (Pubitemid 37345352)
61. Sims, J. E., and D. E. Smith. 2010. The IL-1 family: regulators of immunity. Nat. Rev. Immunol. 10:89-102.
62. Smith, F. O., J. A. Klapper, J. R. Wunderlich, S. A. Rosenberg, and M. E. Dudley. 2009. Impact of a recombinant fowlpox vaccine on the efficacy of adoptive cell therapy with tumor infiltrating lymphocytes in a patient with metastatic melanoma. J. Immunother. 32:870-874.
63. Swiecki, M., and M. Colonna. 2010. Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and tolerance. Immunol. Rev. 234:142-162.
64. Tabeta, K., et al. 2004. Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc. Natl. Acad. Sci. U. S. A. 101:3516-3521.
65. Takeuchi, O., et al. 1999. Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall components. Immunity 11:443-451. (Pubitemid 29504199)
66. Townsley, A. C., and B. Moss. 2007. Two distinct low-pH steps promote entry of vaccinia virus. J. Virol. 81:8613-8620. (Pubitemid 47242835)
67. Townsley, A. C., A. S. Weisberg, T. R. Wagenaar, and B. Moss. 2006. Vaccinia virus entry into cells via a low-pH-dependent endosomal pathway. J. Virol. 80:8899-8908. (Pubitemid 44359964)
68. Vanderplasschen, A., M. Hollinshead, and G. L. Smith. 1998. Intracellular and extracellular vaccinia virions enter cells by different mechanisms. J. Gen. Virol. 79:877-887.
69. Vercammen, E., J. Staal, and R. Beyaert. 2008. Sensing of viral infection and activation of innate immunity by Toll-like receptor 3. Clin. Microbiol. Rev. 21:13-25.
70. Villadangos, J. A., and P. Schnorrer. 2007. Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo. Nat. Rev. Immunol. 7:543-555.
71. Wang, Y., G. Chaudhri, R. J. Jackson, and G. Karupiah. 2009. IL-12p40 and IL-18 play pivotal roles in orchestrating the cell-mediated immune response to a poxvirus infection. J. Immunol. 183:3324-3331.
72. Willingham, S. B., et al. 2007. Microbial pathogen-induced necrotic cell death mediated by the inflammasome components CIAS1/cryopyrin/NLRP3 and ASC. Cell Host Microbe 2:147-159. (Pubitemid 47355205)
73. Yamamoto, M., et al. 2003. Role of adaptor TRIF in the MyD88-independent Toll-like receptor signaling pathway. Science 301:640-643. (Pubitemid 36927946)
74. Yanai, H., et al. 2009. HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses. Nature 462:99-103.
75. Zhao, Y., et al. 2009. The adaptor molecule MyD88 directly promotes CD8 T cell responses to vaccinia virus. J. Immunol. 182:6278-6286.
76. Zhu, J., J. Martinez, X. Huang, and Y. Yang. 2007. Innate immunity against vaccinia virus is mediated by TLR2 and requires TLR-independent production of IFN-beta. Blood 109:619-625. (Pubitemid 46105962)
77. Zucchini, N., et al. 2008. Overlapping functions of TLR7 and TLR9 for innate defense against a herpesvirus infection. J. Immunol. 180:5799-5803.